Global Swine Pneumonia Market, By Diagnosis (Serologic Tests, Polymerase Chain Reaction (PCR) Test, Others), Treatment (Vaccination, Antibiotics, Antibacterial, Others), Market Type (Over-the-Counter (OTC), Prescription), End-Users (Veterinary Hospitals, Veterinary Specialty Clinics, Others), Distribution Channel (Veterinary Hospital Pharmacy, Retail Pharmacy, Veterinary Research Institute, Others) – Industry Trends and Forecast to 2029
Market Analysis and Size
Pneumonia is a common lower respiratory tract infection that compromises animal health and reduces individual and herd performance in pigs. Bacteria, viruses, parasites, dramatic diurnal temperature variations, chemicals (manure gas), dust, and other respiratory tract irritants from the environment are all possible causes of pneumonia. Injectable antibacterial are the best treatment for swine with pneumonia signs like pounding or coughing. The right diagnosis of the various causes of pneumonia is critical for the proper treatment of individual animals as well as the treatment, management, and prevention of pneumonia in swine herds.
Data Bridge Market Research analyses that the swine pneumonia market was valued at USD 491.6 million in 2021 and is expected to reach USD 777.64 million by 2029, registering a CAGR of 5.90% during the forecast period of 2022 to 2029. The market report curated by the Data Bridge Market Research team includes in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
Swine pneumonia is a disease of the lower respiratory tract that affects the health of pigs and reduces individual and herd performance. This illness can cause lung inflammation, subsequent bacterial infection, and significant mortality in pigs, as well as a financial burden on the swine industry. Pneumonia in pigs is characterized by coughing and thumping (shallow, fast breathing). Swine respiratory disorders, according to several studies, are a combination of infectious diseases and one of the leading causes of death in nursery pigs.
Report Scope and Market Segmentation
2022 to 2029
2020 (Customizable to 2019 - 2014)
Revenue in USD Million, Volumes in Units, Pricing in USD
Diagnosis (Serologic Tests, Polymerase Chain Reaction (PCR) Test, Others), Treatment (Vaccination, Antibiotics, Antibacterial, Others), Market Type (Over-the-Counter (OTC), Prescription), End-Users (Veterinary Hospitals, Veterinary Specialty Clinics, Others), Distribution Channel (Veterinary Hospital Pharmacy, Retail Pharmacy, Veterinary Research Institute, Others)
U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America
Market Players Covered
Sanofi (France), F. Hoffmann-La Roche Ltd. (Switzerland), Mallinckrodt (US), Elanco (US), Boehringer Ingelheim International GmbH. (Germany)GlaxoSmithKline plc (UK), Novartis AG (Switzerland), Bayer AG (Germany), Eli Lilly and Company (US), Merck & Co., Inc. (US), AstraZeneca (UK), Johnson & Johnson Private Limited (US), Cipla Inc. (US), Abbott (US), AbbVie Inc. (US), Sun Pharmaceutical Industries Ltd. (India), Aurobindo Pharma (India), Lupin (India)
Swine Pneumonia Market Dynamics
- Increasing prevalence of porcine reproductive respiratory syndrome in animals
The rising prevalence of porcine reproductive respiratory syndrome in animals is estimated to enhance the swine pneumonia market's growth. The rising prevalence rate of this syndrome is due to poor environment, swine, poor ventilation and humidity conditions and increased movement of carrier pigs which will further influence the market dynamics.
- Increasing investment for healthcare infrastructure
Another significant factor influencing the growth rate of swine pneumonia market is the rising healthcare expenditure which helps in improving its infrastructure. Also, various government organizations aims to improve the healthcare infrastructure by increasing funding and this will further influence the market dynamics.
Furthermore, rising initiatives by public and private organizations to spread awareness about benefit of vaccination in among animals will expand the swine pneumonia market. Additionally, rising demand for pneumonia vaccine among consumers will result in the expansion of Swine pneumonia market.
- Increase in the number of research and development activities
Moreover, the market's growth is fueled by an increase in the number of research and development activities. This will provide beneficial opportunities for the Swine pneumonia market growth. Along with this, rising drug approvals and launches will further propel the market’s growth rate.
Moreover, rising investment for the development of advanced technologies and increase in the number of emerging markets will further provide beneficial opportunities for the Swine pneumonia market growth during the forecast period.
On the other hand, high cost high cost associated with the treatment will obstruct the growth rate of market. The dearth of skilled professionals and lack of healthcare infrastructure in developing economies will challenge the Swine pneumonia market. Additionally, strict regulatory policies and lack of awareness among people will act as restrain and further impede the growth rate of market during the forecast period of 2022-2029.
This swine pneumonia market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the Swine pneumonia market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Patient Epidemiology Analysis
Swine pneumonia market also provides you with detailed market analysis for patient analysis, prognosis and cures. Prevalence, incidence, mortality, adherence rates are some of the data variables that are available in the report. Direct or indirect impact analyses of epidemiology to market growth are analysed to create a more robust and cohort multivariate statistical model for forecasting the market in the growth period.
COVID-19 Impact on Swine Pneumonia Market
Since its emergence in December 2019, the COVID-19 virus has spread to nearly every country on the planet, prompting the World Health Organization (WHO) to declare it a public health emergency. COVID-19, a new coronavirus, was identified as the causal agent in the pneumonia cases. This virus spread quickly over the world, killing a large number of people. COVID-19 was labelled a global pandemic by the World Health Organization (WHO) in March 2020, and rigorous measures to prevent the disease's spread were recommended. Since then, the pandemic has delayed the expansion of the healthcare sector and disrupted the supply chain. Furthermore, governments in a number of nations had imposed nationwide lockdowns in order to halt the spread of COVID-19. Similarly, healthcare organizations in numerous nations throughout the world were having difficulty continuing their supply chain activities. The Swine pneumonia market was hampered by the supply chain slowness.
Global Swine Pneumonia Market Scope
The swine pneumonia market is segmented on the basis of diagnosis, treatment, market type, end-users and distribution channel. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
- Serologic Tests
- Polymerase Chain Reaction (PCR) Test
- Over-the-Counter (OTC)
- Veterinary Hospitals
- Veterinary Specialty Clinics
- Veterinary Hospital Pharmacy
- Retail Pharmacy
- Veterinary Research Institute
Swine Pneumonia Market Regional Analysis/Insights
The swine pneumonia market is analysed and market size insights and trends are provided by country, diagnosis, treatment, market type, end-users and distribution channel as referenced above.
The countries covered in the swine pneumonia market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America
North America dominates the swine pneumonia market because of the growing awareness about vaccination among the animal owners and rising healthcare expenditure in this region. Additionally, the presence of major key players will further propel the market’s growth rate in this region.
Asia-Pacific are expected to grow during the forecast period due to rising incidence of swine pneumonia which further lead to the high vaccination demand in this region. Also, development of healthcare infrastructure will further propel the market’s growth rate in this region.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Competitive Landscape and Swine Pneumonia Market Share Analysis
The swine pneumonia market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to Swine pneumonia market.
Some of the major players operating in the swine pneumonia market are:
- Sanofi (France)
- F. Hoffmann-La Roche Ltd. (Switzerland)
- Mallinckrodt (US)
- Elanco (US)
- Boehringer Ingelheim International GmbH. (Germany)
- GlaxoSmithKline plc (UK)
- Novartis AG (Switzerland)
- Bayer AG (Germany)
- Eli Lilly and Company (US)
- Merck & Co., Inc. (US)
- AstraZeneca (UK)
- Johnson & Johnson Private Limited (US)
- Cipla Inc. (US)
- Abbott (US)
- AbbVie Inc. (US)
- Sun Pharmaceutical Industries Ltd. (India)
- Aurobindo Pharma (India)
- Lupin (India)